Evidence map›Paper›PMID 40143012›Full record

ArticlePharmaceutics2025

Innovative Hydrocortisone Acetate and Pramoxine Hydrochloride Topical Cream Formulations for Anorectal Conditions: Enhanced In Vitro Release Profile.

Onur Pinarbasli, Nurdan Atilgan, Ezgi Turkes, Nagehan Sarracoglu, Asuman Aybey Doganay

Abstract read
In one paragraph

Article in Pharmaceutics, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors.

Onur PinarbasliResearch and Development Center, Ilko Pharmaceuticals, Ankara 06800, Turkey.ORCID 0000-0001-7091-683X
Nurdan AtilganResearch and Development Center, Ilko Pharmaceuticals, Ankara 06800, Turkey.
Ezgi TurkesResearch and Development Center, Ilko Pharmaceuticals, Ankara 06800, Turkey.
Nagehan SarracogluResearch and Development Center, Ilko Pharmaceuticals, Ankara 06800, Turkey.
Asuman Aybey DoganayResearch and Development Center, Ilko Pharmaceuticals, Ankara 06800, Turkey.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

This study focuses on analyzing the in vitro release characteristics, as well as improving the penetration rate and stability of hydrocortisone acetate and pramoxine. This medication combination (hydrocortisone and pramoxine) is the first generic drug product utilized to alleviate minor pain, itching, swelling, and discomfort associated with anorectal conditions such as hemorrhoids.

Indexed as

anorectal disordersHPLChydrocortisone acetatein vitro releasepramoxine hydrochloride

Identifiers

PMID40143012
PMCPMC11944865

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.